RELY, a randomized trial of dabigatran, a oral direct thrombin inhibitor, compared to warfarin in 18,113 patients with atrial fibrillation at high risk of stroke; Atrial fibrillation ablation versus treatment; ACTIVE-I, a randomized evaluation of irbesartan versus placebo in patients with atrial fibrillation
Link to this comment:
All Comments (0)